Bachem Holding AG
BANB
Rankning i aktier
#2525
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aktiekurs
$100.24
Marknadsvärde
$7.51B
Förändring (1 dag)
-1.84%
Förändring (1 år)
48.99%
Land
CH
Handel Bachem Holding AG (BANB)
Kategori
Healthcare
Aktiekurshistorik för Bachem Holding AG (BANB)
Högsta slutkurs: $105.12 den 2026-10-01
Lägsta slutkurs: $13.47 den 2001-03-01
Lägsta slutkurs: $13.47 den 2001-03-01
Aktiekurshistorik för Bachem Holding AG från 2001 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 26.87% |
| 2025 | -3.05% |
| 2024 | -5.47% |
| 2023 | -16.69% |
| 2022 | -35.59% |
| 2021 | 68.81% |
| 2020 | 169.92% |
| 2019 | 28.96% |
| 2018 | -16.46% |
| 2017 | 68.14% |
| 2016 | 64.94% |
| 2015 | 3.94% |
| 2014 | -8.15% |
| 2013 | 45.10% |
| 2012 | -0.04% |
| 2011 | -34.01% |
| 2010 | -12.09% |
| 2009 | -5.58% |
| 2008 | -20.36% |
| 2007 | 13.73% |
| 2006 | 32.09% |
| 2005 | 1.28% |
| 2004 | 12.61% |
| 2003 | 11.00% |
| 2002 | -19.59% |
| 2001 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
